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Hydrogen  sulﬁde  (H2S)  is  an  endogenous  gasotransmitter  in  human  physiology  and  inﬂammatory  dis-
ease,  however,  with  limited  knowledge  of  how  signal  transduction  pathways  are  involved  in  immune
cells. To examine  the  effects  of  sulﬁde  on relevant  intracellular  signaling  in  human  peripheral  blood
mononuclear  cells  (PBMCs),  we  stimulated  healthy  donor  PBMCs  with  sodium  hydrosulﬁde  (NaHS,
1–1000  M)  to mimic  H2S stimulation,  and  analyzed  phosphorylation  of  p38  mitogen  activated  pro-
tein  kinase  (MAPK)  (pT180/pY182),  NF-B  p65 (pS529),  Akt (pS473)  and  CREB/ATF1  (pS133/pS63)  with
ﬂow  and  mass  cytometry.  In contrast  to  transient  effects in subsets  of lymphocytes,  classical  monocytes
demonstrated  sustained  phosphorylation  of  p38,  Akt and  CREB/ATF1.  NaHS  induced  calcium  dependent
phosphorylation  of  p38,  Akt and  CREB,  but  not  NF-B, and the  phosphorylation  of  Akt was  partly  depen-
dent  on p38,  indicative  of  p38-Akt  crosstalk.  Attenuation  of these  effects  by  molecules  targeting  p38 and
Hsp90  indicated  Hsp90  as  a possible  target  for H2S-induced  activation  of  p38.  These  results  provide  a
description  of  a NaHS-induced  signal  transduction  pathway  in human  primary  immune  cells  that  may
have  relevance  for  the role  of sulﬁdes  in  inﬂammation.
©  2016  The  Authors.  Published  by Elsevier  Ltd. This  is an open  access  article  under  the  CC BY  license
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at room temperature for 15 min  prior to washing with saline. Cells
were centrifuged at 1200 rpm for 5 min  and subsequently resus-
pended in ice-cold methanol. Cells were immediately stained for
ﬂow cytometry or stored at −80 ◦C until staining. For mass cytom-A. Sulen et al. / Pharmacolog
. Introduction
Hydrogen sulﬁde (H2S) is a colorless malodorous gas that
as received a substantial interest as an important gasotrans-
itter in regulation of inﬂammation [1–3]. H2S is produced
ndogenously through the transsulfuration or 3-mercaptopyruvate
ulfurtransferase/H2S pathway [4–7], and the concentration of
ree H2S in plasma is below 1 M [8,9]. The concentration of
ndogenous H2S is increased during sepsis, hemorrhagic shock
nd in cardiovascular disease [10–12]. Higher levels of H2S are
lso measured in synovial ﬂuid of chronically inﬂamed joints in
heumatoid arthritis patients [13,14]. As an exogenous source,
nhalation of higher than ambient concentrations of H2S is esti-
ated to lead to an increase in plasma sulﬁde concentration [15].
urther, H2S-releasing drugs are also developed and used for their
nti-inﬂammatory properties in treatment of gastrointestinal dis-
rders [16]. However, the role of H2S as a possible mediator during
nﬂammation remains elusive, with disparate inﬂammatory effects
ttributed to this gasotransmitter [10,11,13,14,17–21].
The transcription factor NF-B is considered a key regulator of
nﬂammation [22,23], and stimulation of the tumor necrosis fac-
or receptors (TNFRs) or Toll like receptors (TLRs) typically activate
oth NF-B p65 and p38 [24,25]. The p38 MAPK signaling pathway
s involved in several aspects of inﬂammation, such as produc-
ion of both pro- and anti-inﬂammatory cytokines, prostaglandin
ynthesis and inducible nitric oxide synthase (iNOS) production
26–30]. H2S is known to modulate NF-B activity through sulfhy-
ration [31,32], and to increase phosphorylation of p38 in beta
ells [33], vascular smooth muscle cells [34], endothelial cells [35]
nd glioma cells [36] but decrease phosphorylation in neutrophils
37]. Activation of protein kinase C (PKC) or the calcium/calmodulin
ependent signaling cascade can both lead to p38 phosphory-
ation [30,38–40]. Preconditioning of cardiomyocytes with H2S
eads to cardioprotection and PKC activation, and this cardio-
rotection is attenuated by the PKC inhibitor chelerythrine [41].
ctivation of conventional PKC isoforms is dependent on calcium
42], and H2S is also reported to inﬂuence calcium homeostasis
n excitable cells [41,43]. Whether H2S activates p38 in PBMCs
nd if PKC or calmodulin dependent signaling is involved is not
nown.
Crosstalk between p38 and the proliferative Akt pathway during
timulation with lipopolysaccharide (LPS) or formyl-methionyl-
eucyl-phenylalanine (fMLP) has been described to take place via
he MAPK-activated protein kinases MK2/3 in macrophages [44]
nd neutrophils [45], respectively. H2S treatment alone increases
hosphorylation of Akt (S473) in rat myocardium tissue [46],
ancreatic acinar cells [47] and endothelial cells [48], but only
n endothelial cells have H2S-induced Akt phosphorylation been
hown to be p38 dependent, indicating p38-Akt crosstalk [48].
kt plays a role in polarization of macrophages differentiation
49], but whether p38-Akt crosstalk takes place in primary mono-
ytes during treatment with H2S is, however, unknown. The use
f comprehensive high dimensional single cell signaling assess-
ent to describe the effects of H2S on signal transduction in
rimary immune cells is so far in its infancy [50], and con-
entional ﬂow cytometry and mass cytometry is a particular
owerful technique suitable for delineating effects of small molec-
lar inhibitors or activators in complex mixtures of blood cells
51–53]. To better understand how this gasotransmitter inﬂuence
mmune cells, we investigated how sodium hydrosulﬁde affects
38 MAP  kinase and NF-B intracellular signaling systems of
BMCs.search 113 (2016) 216–227 217
2. Materials and methods
2.1. Chemicals
Sodium hydrosulﬁde (NaHS) was acquired from Sigma-Aldrich
(St. Louis, MO,  USA), and a fresh stock was  prepared prior to
each experiment by dissolving it in saline at 0.2 M. The molecules
ryanodine, 2-aminoethoxydi-phenyl borate (2-APB), W-7, KN-93,
geldanamycin and ethylene glycol-bis(2-aminoethyl)-N,N,N,N-
tetraacetic acid (EGTA) were purchased from Sigma-Aldrich.
BAPTA-AM was  purchased from Thermo Fisher Scientiﬁc (Walt-
man, MA,  USA). The molecules RO318220, GÖ6976, LY333531,
chelerythrine and PKC-412 were purchased from Santa Cruz
(Dallas, TX, USA). BIRB796 and PH-797804 were acquired from
Selleckchem (Houston, TX, USA). All molecules except EGTA were
dissolved in DMSO. EGTA was dissolved in double distilled water
(ddH20) adjusted to pH 7.5. Paraformaldehyde (16%) was pur-
chased from Thermo Fisher Scientiﬁc. Molecules used in the
automated screen were selected from libraries from Selleckchem,
Enzo Life Sciences (Farmingdale, NY, USA), Tocris Bioscience (Bris-
tol, UK) or Sigma (details in Supplemental Table S2).
2.2. Culturing of THP-1 and Jurkat cells and isolation of PBMCs
The T-cell leukemia cell line Jurkat (Clone E6-1) and the myeloid
cell line THP-1 were purchased from ATCC (American Type Culture
Collection, Manassas, VA, USA). Dr. Vibeke Andresen (University
of Bergen, Norway) kindly provided the NF-B/Jurkat/GFPTM Tran-
scriptional Reporter Cell Line (System Biosciences, Palo Alto, CA,
USA). All cells were cultured in Roswell Park Memorial Insti-
tute (RPMI)-1640 medium (Sigma-Aldrich, Inc. St. Louis, MO,  USA)
with 10% heat-inactivated Fetal Bovine Serum (PAA Laboratories
GmbH, Austria), 1% L-glutamine (Sigma-Aldrich) and 1% Peni-
cillin/Streptomycin (Sigma-Aldrich). Cells were cultured at 5% CO2
humidiﬁed atmosphere at 37 ◦C. PBMCs were acquired from ran-
dom healthy blood donors from the Department of Immunology
and Transfusion Medicine, Haukeland University Hospital, Bergen,
Norway. The local research ethics committee at Haukeland Univer-
sity Hospital approved the study (Regionale komiteer for medisinsk
og helsefaglig forskningsetikk, REK), and the donors provided
informed consent. Blood was collected in accordance with the
Helsinki Declaration. Blood collected in EDTA tubes was  diluted in
saline (1:2) prior to density gradient separation (LymphoprepTM,
Stemcell Technologies). PBMCs were isolated and washed two
times in sterile saline prior to resuspension at 0.5 × 106 cells/ml
in complete RPMI medium. PBMCs were kept in an incubator at
5% CO2 humidiﬁed atmosphere at 37 ◦C for at least 60 min prior to
experiments.
2.3. In vitro treatment of cells
For phospho ﬂow cytometry experiments, PBMCs or cell lines
were transferred to polypropylene ﬂow cytometry tubes purchased
from Sarstedt (Germany). After treatment of cells for the desired
treatment time, cells were ﬁxed by adding 16% paraformaldehyde
to a ﬁnal concentration of 4%. The ﬁxation process was carried out
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try analysis, cells were treated in accordance with protocols from
luidigm.
.4. Phospho speciﬁc ﬂow cytometry
In order to reduce antibody consumption and to achieve
ccurate staining, samples were ﬂuorescently barcoded prior to
ntibody staining [54]. PBMCs were barcoded with the amine-
eactive ﬂuorescent dyes Paciﬁc Blue and Paciﬁc Orange while
HP-1 cells were barcoded with Alexa568 and Paciﬁc Blue (all from
hermo Fisher Scientiﬁc). Staining of cells with phospho speciﬁc
ntibodies and antibodies for immunophenotyping was carried
ut as previously described [50,55]. The cells were stained with
onocyte surface marker CD163 PE (Clone MAC2-158, Trillium
iagnostics), T-cell marker CD5 PerCP-Cy5.5 (Clone L17F12, BD),
nti p38 MAPK (pT180/pY182, clone 36/p38, BD), Anti-CREB/ATF1
pS133/pS63, clone J151-21, BD) or Anti-Akt (pS473, clone M89-
1). After antibody staining the samples were analyzed on a
ACS Fortessa ﬂow cytometer (BD). For the high throughput small
olecule inhibitor screen the standard phosphoﬂow method was
ully automated in 384-well format using a Microlab Star liquid
andling robot (Hamilton).
.5. Mass cytometry analysis
Stimulated cells were barcoded using the 20-plex barcoding kit
Fluidigm) and stained with a single panel of 19 mass-tagged anti-
odies (Supplemental Table S1), in accordance with cell staining
rotocols (Fluidigm). Cells were analyzed on a Helios mass cytome-
er (Fluidigm) at approx. 400 events/s. An automated barcode
econvolution algorithm was used to identify barcoded samples
nd to remove cell doublets. Unsupervised multiparameter viSNE
nalysis was used to identify cellular subsets of PBMCs [56]. All
ntibodies used for mass cytometry was purchased from Fluidigm
nd are listed in Supplemental Table 1.
.6. Cell death assay
Viability of PBMCs treated with different concentrations of NaHS
as determined by staining the cells with Annexin V Alexa® 647
onjugate (BD) and analysis of the cells with ﬂow cytometry. Viabil-
ty of Jurkat cells was determined with a Colony-Forming Cell Assay
sing MethoCultTM H4434 Classic (StemcellTM Technologies).
.7. ATP measurements
Concentrations of ATP in PBMCs were determined with the
ellTiter-Glo® Luminescent Cell Viability Assay (Promega, Madi-
on, WI,  USA). The luminescence was measured with the Inﬁnite®
200 reader (Tecan Trading AG, Switzerland).
.8. Statistical analysis
A two-tailed Student’s t-test was carried out in Prism 6 to com-
are phosphorylation levels between control groups and treatment
roups in the different cell types. The signiﬁcance level was  set to
.05.
. Results
.1. NaHS induces phosphorylation of p38 (T180/Y182) in
eripheral blood mononuclear cells
Stimulation of PBMCs with NaHS followed by evaluation of
hosphorylated p38 with western blotting and phospho speciﬁcsearch 113 (2016) 216–227
ﬂow cytometry showed a concentration-dependent increase in p-
p38 (Fig. 1a, b). Correlation between quantitated bands from the
western blot with mean ﬂuorescent intensities (MFI) indicates
high speciﬁcity for the ﬂow cytometry assay (Fig. 1c). To deter-
mine the optimal stimulation time, PBMCs were stimulated with
NaHS (1 mM)  for various treatment times and evaluated for p-p38
(Fig. 1d). Phosphorylation peaked after 5–10 min, and the phospho-
rylation of p-p38 was  sustained and transient in monocytes and
T-cells, respectively. The phosphorylation remained sustained in
monocytes for 4 h (longest treatment time tested, data not shown).
With the optimal treatment time for signaling, PBMCs were stimu-
lated with increasing concentrations of NaHS (1–1000 M,  10 min)
and evaluated for p-p38 (Fig. 1e, f). NaHS displayed an EC50 of
183 M (95% CI (53, 642)) in T-cells and 95 M (95% CI (77, 117)) in
monocytes (Fig. 1f). For the remaining signal transduction exper-
iments in the study, cells were stimulated with 1 mM NaHS for
10 min  unless otherwise stated. To investigate how NaHS effects p-
p38 in the different types of monocytes and lymphocytes present
in PBMCs, a mass cytometry panel counting 19 antibodies was
developed for immune phenotyping of PBMCs and evaluation of
signal transduction in these cells during treatments. The com-
plex immune phenotypic data was analyzed with the unsupervised
viSNE analysis, and manually divided into different subsets of lym-
phoid and myeloid cells (Supplemental Fig. S3). Phosphorylation
of p38 was observed to increase in CD4 T-cells, CD8 T-cells, B-
cells, natural killer (NK) cells, basophils, and both classical and
non-classical monocytes after stimulation with NaHS (Fig. 1g). The
phosphorylation remained high after 60 min  in classical mono-
cytes, but not in non-classical monocytes. CD123+ dendritic cells
(DCs) did not display a change in p-p38 during stimulation with
NaHS. Further, NaHS was found to induce substantial cell death
at 1 mM but not at 0.1 mM,  as determined in an Annexin V assay
(Fig. 1h). Given that H2S is a potent inhibitor of cytochrome-c
oxidase and mitochondrial respiration [57], ATP was measured in
PBMCs treated in vitro with concentrations shown to phosphorylate
p38 (Fig. 1i). No signiﬁcant changes were observed when compared
to vehicle treated cells.
3.2. Phosphorylation of p38 (T180/Y182) by NaHS takes place
independently of extracellular calcium but is dependent on
intracellular calcium in PBMCs
Given that H2S is reported to inﬂuence calcium homeostasis
in various cell types, we  therefore sought to investigate if the
observed NaHS-induced phosphorylation of p38 in PBMCs could
be dependent on calcium. When evaluating the role of extracellu-
lar calcium, preincubation with EGTA did not attenuate the increase
in p-p38 induced by any concentration of NaHS compared to cells
not pre-incubated with EGTA (Fig. 2a). Treating PBMCs with EGTA
and ionomycin (0.5 g/ml, 10 min) validated the effect of calcium
chelation by EGTA on p-p38 (Fig. 2b). Using a different chelator
of extracellular calcium (BAPTA) in combination with NaHS gave
the same results (Fig. 2c). When evaluating the role of intracellu-
lar calcium, preincubation with BAPTA-AM did result in complete
attenuation of NaHS-induced p38 phosphorylation as compared to
cells where calcium was not chelated (Fig. 2d). Repeating the exper-
iments with BAPTA and BAPTA-AM on PBMCs from additional blood
donors conﬁrmed these results (Fig. 2e).
3.3. Pharmacological inhibition of IP3R, RyR, calmodulin, CaMKII
or PKC do not inhibit NaHS-induced modulation of p38
phosphorylation (T180/Y182) in PBMCsThe classical regulator of calcium release from the endo-
plasmatic reticulum (ER) during PKC activation is inositol 1,4,5
trisphosphate receptor (IP3R) [58]. Calcium release from ER via
A. Sulen et al. / Pharmacological Research 113 (2016) 216–227 219
Fig. 1. In vitro treatment of PBMCs with sodium hydrosulﬁde induces phosphorylation of p38 (T180/Y182). (a) Cropped western blots of lysates from PBMCs treated with
NaHS  (10 min) or ionomycin (0.5 g/ml, 10 min). Uncropped images are available in Supplemental Figs. S1 and S2 . (b) Histogram overlay displays p-p38 T180/Y182 or
isotype control stained CD45+ PBMCs stimulated with NaHS (10 min) or ionomycin (0.5 g/ml, 10 min). (c) Dot plot comparing PBMC p-p38 mean ﬂuorescent intensity with
p-p38/COX IV ratios. Solid line represents linear regression line. (d, e) Histogram overlays display ratio (treated/ctr) of p-p38 T180/Y182 in T-cells (CD5 + ) and monocytes
(CD163 + ) stimulated with 1 mM NaHS for increasing treatment times (5–55 min) (d) or increasing concentrations of NaHS (1–1000 M)  for 10 min  (e). (f) PBMCs from healthy
donors  (n = 3) were stimulated with NaHS (1–1000 M,  10 min), and p-p38 MFI  determined by ﬂow cytometry was  used to make concentration-response curves (mean ± SD).
(g)  Heat map  displaying median metal intensity (MMI) of p-p38 (T180/Y182) in subsets of PBMCs identiﬁed in Supplemental Fig. S3. The cells were treated with NaHS (1 mM,
10  or 60 min) or LPS (1.0 g/ml, 10 min). (h) Plot displaying percentage Annexin V negative cells (mean ± SD) in PBMCs treated with NaHS (0.1 or 1.0 mM,  10 min  or 24 h)
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P3R is activated by the ligand IP3, a molecule produced by
hospholipase C (PLC) through hydrolysis of phosphatidylinositol
,5-bisphosphate (PIP2) during receptor activation [58]. In order
o assess whether the observed signaling effects of NaHS were
ue to calcium mobilization via IP3Rs, PBMCs were pre-incubated
ith the IP3R antagonist 2-aminoethoxydiphenyl borate (2-APB)
efore stimulation with NaHS, and evaluated for p-p38. This did
ot prevent increased p-p38 induced by NaHS (Fig. 3a). Intracellular
alcium release in immune cells is also suggested mediated by the
yanodine receptors (RyRs) [59]. While RyRs are highly expressed
n brain tissue and in skeletal and cardiac muscle tissue, the expres-
ion in PBMCs are limited to only some subsets of cells and at low
evels [59]. To assess whether NaHS-induced elevated p-p38 could
e due to calcium mobilization via RyRs, PBMCs were preincubated
ith antagonistic concentrations of ryanodine before stimulation0.05, ****p ≤ 0.0001, ns p > 0.05). (i) Plot displaying ATP concentrations (mean ± SD)
ne (1 M) for 10 min. Student’s t-tests were conducted to compare treated groups
with NaHS, and evaluated for p-p38. Antagonistic concentrations
of ryanodine had no observed effect on the phosphorylation of p38
induced by NaHS (Fig. 3c). The plant alkaloid ryanodine functions as
an RyR agonist at low concentrations (nM) by locking the receptor
in an open state, while it functions as an RyR antagonist at higher
concentrations (M)  [60]. Incubating PBMCs with agonistic con-
centrations of ryanodine alone (1–100 nM,  10 min) did not result
in any change in p-p38 (data not shown).
To assess whether the inhibition of calmodulin or
Ca2+/calmodulin-dependent protein kinase II (CaMKII) could
attenuate the increase in p-p38, PBMCs were preincubated with
the calmodulin inhibitor W-7  or the CaMKII inhibitor KN93 prior to
stimulation with NaHS. None of the inhibitors caused a substantial
attenuation of the p38 phosphorylation induced by NaHS (Fig. 3b).
In accordance with this, repeating these experiments with the
220 A. Sulen et al. / Pharmacological Research 113 (2016) 216–227
Fig. 2. Phosphorylation of p38 (T180/Y182) during in vitro treatment of PBMCs
with sodium hydrosulﬁde is independent of extracellular calcium but dependent on
intracellular calcium. (a-d) Histogram overlays display median ratio (treatment/ctr)
of p-p38 in T-cells and monocytes. (a) Cells were treated with NaHS (10, 100 or
1000 M for 10 min) or left untreated, after preincubation with or without EGTA
(2  mM,  15 min). (b) PBMCs were stimulated with ionomycin (0.5 g/ml, 10 min) or
left untreated, after preincubation with or without EGTA (2 mM,  15 min). (c) PBMCs
were stimulated with NaHS (10 min) or left untreated, after preincubation with or
without BAPTA (2 mM,  15 min). (d) PBMCs were stimulated with NaHS (10 min) or
left  untreated, after preincubation with or without BAPTA-AM (20 M, 60 min). (e)
Plot  displaying p-p38 MFIs (mean ± SD) of T-cells and monocytes in treated (NaHS,
1  mM,  10 min) and untreated samples, with or without preincubation with BAPTA
(
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Fig. 3. Phosphorylation of p38 during in vitro treatment of PBMCs with sodium
hydrosulﬁde is independent of inhibition of IP3R, RyR, calmodulin, CaMKII and PKC.
(a-d) Histogram overlays display median ratio (treatment/ctr) of p-p38 in T-cells
and  monocytes. PBMCs were stimulated with NaHS (1 mM,  10 min) or left untreated,2  mM,  15 min) or BAPTA-AM (20 M,  60 min). Student’s t-tests were conducted to
ompare p-p38 in treated groups (NaHS) and their respective controls (**p ≤ 0.01,
**p  ≤ 0.001, ****p ≤ 0.0001, ns p > 0.05).
onocytic cell line THP-1 gave similar results (Supplemental Fig.
4). To investigate whether pharmacological inhibition of PKC
ould attenuate the increase in p-p38, PBMCs were preincubated
ith GÖ6976, LY333531 or chelerythrine prior to stimulation with
aHS. GÖ6976 and LY333531 did not attenuate the NaHS-induced
ffect on p-p38 (Fig. 3d). Chelerythrine alone did induce a large
hosphorylation of p38, and after preincubating with chelerythrine
here was no observable difference in p-p38 between control and
aHS treated cells. Similar effects by GÖ6976 and chelerythrine onafter preincubation for 15 min  with or without (a) 2-APB (300 M),  (b) W-7  (50 M)
or  KN-93 (5 M),  (c) ryanodine, and (d) GÖ6976 (3 M),  LY333531 (7.5 M)  or
chelerythrine (3 M).
NaHS-induced p-p38 were observed in THP-1 cells (Supplemental
Fig. S4). Incubating THP-1 cells with two  additional PKC inhibitors
(PKC412 and RO318220) prior to stimulation with NaHS did not
prevent p-p38 induction (Supplemental Fig. S4).
3.4. Inhibitors targeting p38 and Hsp90 attenuate the increase in
phosphorylation of p38 (T180/Y182) induced by NaHS
In order to further elucidate how p38 is phosphorylated by
NaHS, Jurkat cells were chosen as a suitable model in which to
carry out an automated high throughput phosphoﬂow screen with
a library of relevant small molecule inhibitors to evaluate how these
molecules inﬂuence the phosphorylation induced by NaHS (Fig. 4a).
Jurkat cells treated with 0.1 or 1.0 mM NaHS did not show signif-
icant less viability compared to vehicle treated cells (determined
with a colony-forming assay, data not shown). Of the 59 compounds
tested (Supplemental Table S2), two p38 inhibitors (BIRB796 and
PH-797804) and the Hsp90 inhibitor geldanamycin signiﬁcantly
attenuated the effect of NaHS on p-p38 (grey box in Fig. 4a). In
addition, three compounds known to target phosphodiesterases
(PDEs), protein kinase A (PKA) and T-type Ca2+ channels appeared
to slightly attenuate the effect of NaHS, however not signiﬁcantly.
The effect of BIRB796, PH-797804 and geldanamycin on p38 phos-
phorylation induced by NaHS was  further validated in primary
PBMCs (Fig. 4b–d). Pre-incubation with geldanamycin attenuated
the effect of NaHS by inducing phosphorylation of p38 alone in both
PBMCs and the Jurkat cells (Fig. 4d and Supplemental Fig. S6).
A. Sulen et al. / Pharmacological Research 113 (2016) 216–227 221
Fig. 4. Inhibitors of p38 and Hsp90 attenuate increase in phosphorylation of p38 induced by NaHS. (a) Jurkat cells were incubated with small molecule inhibitors (10 M)
in  25 min  prior to stimulation with NaHS (1 mM,  2.5 min). Plot displays the ratio between p38 phosphorylation induced by NaHS when preincubating with and without
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sompounds (*p < 0.05, t-test (compared to “No compound 1”)). The grey area represe
ithout compounds, see Supplemental Figs. S5 and S6 for quality control data). All c
argeting p38 and Hsp90 (1 and 10 M,  25 min) on phosphorylation of p38 induced
.5. NaHS induces calcium-dependent phosphorylation of Akt
hat is partly dependent on p38 in PBMCs
To investigate if Akt is phosphorylated during treatment of
BMCs with H2S, blood cells were stimulated with NaHS (1 mM)
or treatment times up to an hour and evaluated for p-Akt (S473)
Fig. 5a). Similar to p38, Akt was phosphorylated in a transient and
ustained manner in T-cells and monocytes, respectively (Fig. 5a).e expected variation in the assay without compounds (determined by 14 replicates
unds were tested in triplicates. (b-d) Histogram overlays display effect of inhibitors
HS (1 mM,  10 min) in PBMCs.
To investigate if this observed phosphorylation of Akt could be
due to crosstalk from the p38 signaling pathway, PBMCs were
preincubated with the indirectly ATP-competitive p38 inhibitor
BIRB796, stimulated with NaHS (1 mM,  10 min) and the phospho-
rylation level of Akt was determined by ﬂow cytometry. Inhibition
of p38 did signiﬁcantly attenuate the induction of p-Akt by NaHS
in monocytes (t-test, p < 0.05), however, not signiﬁcantly in T-
cells (Fig. 5b-c). Inhibition of p38 also signiﬁcantly attenuated the
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Fig. 5. NaHS induces phosphorylation of Akt that is partly dependent on p38 and dependent on intracellular calcium in PBMCs (a) Histogram overlay displays median ratio
(treatment/ctr) of p-Akt in T-cells and monocytes stimulated with NaHS (1 mM)  for treatment times up to 55 min. Vehicle treated cells were used as control. (b) Histogram
overlay displays median ratio (treatment/ctr) of p-Akt in T-cells and monocytes stimulated with NaHS (10 min) or left untreated, after preincubation with or without
BIRB796 (25 min). (c) Plot displaying p-Akt MFIs (mean ± SD) of T-cells and monocytes in treated (NaHS, 10 min) and untreated samples, with or without preincubation with
BIRB796 (25 min). Student’s t-tests were conducted to compare p-Akt in combination groups (NaHS + BIRB796) with groups only treated with NaHS (*p ≤ 0.05, ns p > 0.05). (d)
Histogram overlay displays median ratio (treatment/ctr) of p-Akt in T-cells and monocytes stimulated with PMA  (1 g/ml, 15 min), LPS (1 g/ml, 15 min) or left untreated,
after  preincubation with or without BIRB796 (25 min). (e-f) Plots displaying p-Akt MFIs (mean ± SD) of (e) T-cells and (f) monocytes in treated (LPS or PMA) and untreated
samples,  with or without preincubation with BIRB796 (25 min). Student’s t-tests were conducted to compare p-Akt in BIRB796 groups with their respective controls (*p ≤ 0.05,
**p  ≤ 0.01, ns p > 0.05). (g) Histogram overlay displays median ratio (treatment/ctr) of p-Akt in T-cells and monocytes stimulated with NaHS (10 min) or left untreated, after
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wreincubation with or without BAPTA (2 mM,  15 min) or BAPTA-AM (20 M,  60 m
reated  (NaHS, 1 mM,  10 min) and untreated samples, with or without preincuba
onducted to compare p-Akt in treated groups (NaHS) with their respective control
nduction of p-Akt by LPS in monocytes (t-test, p < 0.01) and by
MA in both cell types (t-test, p < 0.05) (Fig. 5d–f). Since intracel-
ular calcium chelation completely attenuated the NaHS-induced
hosphorylation of p38, this was also investigated for p-Akt. Intra-
ellular calcium chelation resulted in a complete inhibition of
ncrease in p-Akt induced by NaHS (Fig. 5g-h).
.6. NaHS induces cAMP responsive element (CRE)-binding
ranscription factor phosphorylation that is dependent on p38 and
ntracellular calcium in PBMCsThe kinase p38 is known to form a signaling pathway involving
RE-binding transcription factors [30]. To investigate the kinetics of
REB/ATF1 phosphorylation during stimulation with NaHS, PBMCs
ere stimulated with NaHS (1 mM)  for treatment times up to an) Plot displaying p-Akt median ﬂuorescent intensities of T-cells and monocytes in
ith BAPTA (2 mM,  15 min) or BAPTA-AM (20 M, 60 min). Student’s t-tests were
s (*p ≤ 0.05, **p ≤ 0.01, ns p > 0.05).
hour and evaluated for p-CREB/ATF-1 with ﬂow cytometry (Fig. 6a).
Similar to p38 and Akt, CREB is phosphorylated in a transient and
sustained manner in T-cells and monocytes, respectively (Fig. 6a).
For testing whether CREB/ATF-1 is downstream of p38, inhibition of
p38 did signiﬁcantly attenuate the NaHS-induced phosphorylation
of CREB/ATF1 in monocytes and T-cells (t-test, p < 0.001) (Fig. 6b-
c). Inhibition of p38 also signiﬁcantly attenuated the induction of
p-CREB/ATF-1 by LPS in monocytes (t-test, p < 0.01), but not by
PMA  in any cell types (Fig. 6d–f). Intracellular calcium chelation
with BAPTA-AM resulted in a complete inhibition of the increase in
monocyte p-CREB/ATF-1 induced by NaHS (Fig. 6g-h). BAPTA-AM
alone increased the phosphorylation of CREB/ATF1 in T-cells, but no
signiﬁcant additional increase was observed when combined with
NaHS (Fig. 6g-h).
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Fig. 6. NaHS induces phosphorylation of CREB/ATF-1 that is dependent on p38 and intracellular calcium in PBMCs. (a) Histogram overlay displays median ratio (treatment/ctr)
of  p-CREB/ATF-1 in T-cells and monocytes stimulated with NaHS (1 mM)  for treatment times up to 55 min. Vehicle treated cells were used as control. (b) Histogram overlay
displays  median ratio (treatment/ctr) of p-CREB/ATF-1 in T-cells and monocytes stimulated with NaHS (10 min) or left untreated, after preincubation with or without BIRB796
(25  min). (c) Plot displaying p-CREB/ATF-1 MFIs (mean ± SD) of T-cells and monocytes in treated (NaHS, 1 mM,  10 min) and untreated samples, with or without preincubation
with  BIRB796 (1 or 10 M,  25 min). Student’s t-tests were conducted to compare p-CREB/ATF-1 in combination groups (NaHS + BIRB796) with groups only treated with NaHS
(***p  ≤ 0.001). (d) Histogram overlay displays median ratio (treatment/ctr) of p-CREB/ATF-1 in T-cells and monocytes stimulated with PMA  (1 g/ml, 15 min), LPS (1 g/ml,
15  min) or left untreated, after preincubation with or without BIRB796 (25 min). (e-f) Plots displaying p-CREB/ATF-1 MFIs (mean ± SD) of (e) T-cells and (f) monocytes in
treated  (LPS or PMA) and untreated samples, with or without preincubation with BIRB796 (25 min). Student’s t-tests were conducted to compare p-CREB/ATF-1 in BIRB796
groups with their respective control groups (**p ≤ 0.01, ns p > 0.05). (g) Histogram overlay displays median ratio (treatment/ctr) of p-CREB/ATF-1 in T-cells and monocytes
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(timulated with NaHS (10 min) or left untreated, after preincubation with or withou
edian ﬂuorescent intensities of T-cells and monocytes in treated (NaHS, 1 mM,  10 m
APTA-AM (20 M,  60 min). Student’s t-tests were conducted to compare p-CREB/AT
.7. NaHS does not activate NF-B
In order to investigate how H2S inﬂuences NF-B in PBMCs,
hese cells were stimulated with NaHS (1 mM),  TNF (20 ng/ml) or
PS (1 g/ml) for ten minutes and evaluated for p-p38 and p-NF-B
S529) with ﬂow cytometry. Stimulation with TNF and LPS induced
hosphorylation of both proteins in the expected cell types (Fig. 7a).
timulation with NaHS induced phosphorylation of p38, but not
F-B in both cell types. Consistent with this, treatment of a NF-
B/Jurkat/GFPTM Transcriptional Reporter Cell Line with increasing
oncentrations of NaHS did not lead to increased green ﬂuorescent
rotein expression, indicating no change in transcriptional activity
Fig. 7b). Mass cytometry analysis of PBMCs stimulated with NaHSTA (2 mM,  15 min) or BAPTA-AM (20 M,  60 min). (h) Plot displaying p-CREB/ATF-1
d untreated samples, with or without preincubation with BAPTA (2 mM,  15 min) or
 treated groups (NaHS) with their respective control groups (**p ≤ 0.01, ns p > 0.05).
(1 mM),  TNF (20 ng/ml) or LPS (1 g/ml) for ten minutes revealed
similar signaling responses, with no change in p-NF-B induced by
NaHS in all subsets (CD4 T-cells, naive CD8 T-cells, memory CD8
T-cells, NK-cells, and both subsets of monocytes) (Fig. 7c-d).
4. Discussion
The actual level of physiological concentrations of H2S in vivo
has been difﬁcult to determine and may  have been overesti-
mated due to limitations in the methodologies applied [61,62].
The widely used methylene blue assay measures acid-labile sul-
phur in addition to free sulﬁde in plasma in the M range [63],
while newer techniques measure free sulﬁde and soluble gas in
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Fig. 7. In vitro treatment of PBMCs with sodium hydrosulﬁde does not modulate p-NF-B. (a) Histogram overlay displays median log2 ratio of p-p38 T180/Y182 and p-
NF-B  in T-cells and monocytes stimulated with NaHS (1 mM,  10 min), LPS (1.0 g/ml, 10 min) or TNF (20 ng/ml, 10 min). Vehicle treated cells were used as control. (b)
Plot  displaying GFP median ﬂuorescent intensities of the NF-B/Jurkat/GFPTM Transcriptional Reporter Cell Line treated with NaHS or TNF (0.25 ng/ml) and incubated for
24  h. Student’s paired t-tests were conducted to compare MFI  in treated groups with the control groups (*p ≤ 0.05, ns p > 0.05). (c) Bivariate viSNE contour plot displaying
identiﬁed subsets of PBMCs; CD4 T-cells (CD3+CD4+), CD8 T-cells (CD3+CD8+), B-cells (CD19+CD20+HLA-DR+), NK cells (CD16+HLA-DR−), Basophils (CD123+CD11c+), CD123+
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ndividually are available in Supplemental Fig. S7. (d) Heat maps displaying the ar
-p38  (T180/Y182), p-NF-B (S529) and IB in subsets of PBMCs identiﬁed in (c).
he nM range [8,9]. It has been pointed out that most studies
ave reported biological effects of H2S in the 10–100 M range
64], this is in line with the present study where a concentration-
esponse relationship between NaHS and p-p38 is detected at
0–1000 M in PBMCs (Fig. 1f). Another sulphur molecule, sodium
hiosulphate (Na2S2O3), is used therapeutically in millimolar serum
oncentration against calciﬁc uremic arteriolopathy, also known as
alciphylaxis [65]. However, the concentrations of free sulﬁde in
lasma from healthy individuals and patients with cardiovascu-
ar disease have been determined to be <1 M [8,12]. Therefore,
ignaling described in the present study is likely detected at supra-
hysiological concentrations of H2S. However, it has been proposed
hat the concentration of H2S in inﬂammatory micro milieu like
ynovial ﬂuid of rheumatoid arthritis patients exceeds what is mea-
ured in blood [13]. This has been determined with the methylene
lue assay, and it is unknown whether these concentrations are
eﬂecting free sulﬁde, acid-labile sulﬁde or both [13]. The use of
echniques that precisely determine free sulﬁde levels could aid
n determining whether the signaling described in the present
tudy is relevant for immune cells in synovial ﬂuid in patients
ith rheumatoid arthritis. However, the lower supra-physiological
oncentrations of sulﬁde used in the present study could be rele-
ant during environmental or occupational exposure to higher than
mbient concentrations of H2S [50]. For comparison, the equiva-
ent plasma sulﬁde concentration during atmospheric exposure of
0 ppm H2S has been estimated equal to 6.5 M [15].
The discussion about physiological relevance for various con-
entrations of H S is also complicated by the presence of2
olysulﬁdes (H2Sn) formed by many of the sodium salts used to
tudy this gas in vitro [66]. Concentrations of H2S in solutions of
aHS are therefore lower than estimated, and polysulﬁdes couldes (HLA-DR+CD14+). All viSNE plots displaying expression of phenotypic markers
change, relative to vehicle treated control, of the median metal intensity (MMI) of
in fact be the active agent. Polysulﬁdes are also generated when
making sulﬁde solutions from H2S gas, implying that studying H2S
separately from polysulﬁdes is practically impossible [66]. Stud-
ies in astrocytes have shown that polysulﬁdes activate a calcium
inﬂux in these cells through opening of transient receptor potential
(TRP) channels at substantial lower concentrations (EC50 91 nM)
compared to what NaHS does (EC50 116 M) [43,67]. Endogenous
polysulﬁdes have been detected in HeLa cells [68], zebra ﬁsh [68]
and brain tissue of rats [67], and have been suggested to be endoge-
nous H2S-derived signaling molecules that modify thiol groups of
cysteines in proteins [66,69]. It is therefore possible that signaling
described in the present study is mediated by nM range concentra-
tions of polysulﬁdes.
This study describes NaHS-induced signaling of p38 with Akt
and CREB/ATF1 as partial and complete downstream proteins,
respectively (Figs. 1, 5 and 6). Interestingly, classical monocytes
displayed a lacking property to down-regulate the signaling com-
pared to lymphocytes. H2S is known to inactivate phosphatases
through sulfhydration [70], and this could indicate that classical
monocytes are particularly prone to such inactivation and thereby
susceptible to long-term inﬂuence by sulﬁdes. Activation of p38 is
known to increase COX-2 expression in these cells [71]. Inhibition
of endogenous H2S synthesis attenuates COX-2 transcription and
prostaglandin production in a colitis rat model [21], and exoge-
nous H2S has also been described to increase COX-2 expression
[72]. Treatment of macrophages with NaSH (100–200 M)  in com-
bination with LPS does result in reduced release of PGE2 [2].
NF-B p65 is essential in mounting a cytokine response after
proinﬂammatory stimuli [23], and its activity is modulated by H2S
[2,31]. However, the stimulation with NaHS alone did not lead to
activation of NF-B p65 (Fig. 7). Whiteman et al. showed that com-
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ination treatment with NaHS and LPS increased NF-B p65 activity
nd secretion of TNF and IL-1 compared to LPS treatment alone
2]. In light of the signaling described in the present study, this
ould be due to partly overlapping signal transduction induced by
PS and NaHS. The lack of NF-B transcriptional activation in the
resent study is in line with a study where stimulation with NaHS
lone did not inﬂuence cytokine production in immune cells [1].
he stress kinase p38 is often referred to as being important in the
ro-inﬂammatory cytokine response, however, such studies often
nvestigate p38 in the context of activated NF-B [28]. Activation of
38 is also known to increase expression of the anti-inﬂammatory
ytokine IL-10 [30], and therapeutic inhibition of p38 in rheumatoid
rthritis patients has so far been disappointing, suggesting that this
rotein is not pivotal in this inﬂammatory disease [73]. In this light,
t could be that activated p38 by NaHS could actually have mostly
nti-inﬂammatory repercussions. Phosphorylation and activation
f Akt by H2S is suggested to lead to survival and angiogenesis
n vascular smooth muscle cells [46] and endothelial cells [48],
espectively. Functional effects of NaHS-induced Akt activation in
BMCs have not been elaborated. However, Akt1 ablation in mice
as been shown to lead to differentiation of macrophages towards
n M1  type [74], and increased activity of the PI3K-Akt-mTOR path-
ay leads to differentiation of human monocytes towards an M2
ype [49]. The latter is considered anti-inﬂammatory; they produce
ess nitric oxide and are involved in tissue repair and resolution of
nﬂammation [75]. Interestingly, mice treated with NaHS prior to
yocardial infarction are reported to exhibit enhanced M2  differ-
ntiation of macrophages in cardiac tissues [76]. Our observation
f NaHS-induced sustained phosphorylation of Akt in monocytes
rovided in the present study could indicate a macrophage differ-
ntiation effect also in human tissue.
To investigate the molecular mechanism of the signaling
nduced by NaHS, the highest concentration used in the present
tudy (1 mM)  was chosen to achieve a clear phosphorylation effect
uitable for combination studies to evaluate preventive effect of
harmacological inhibitors or calcium chelators. H2S has been
eported to inﬂuence several processes that could be relevant
or p38; cyclic nucleotide signaling [77], ion channel function
78], tyrosine phosphatase activity [79] and PKC activity [41].
xperiments were carried out in PBMCs or Jurkat cells where
harmacological inhibition of these processes was  investigated for
otential effect on NaHS-induced phosphorylation of p38 (Figs. 2-
). Notably, chelation of intracellular calcium and inhibitors of p38
nd Hsp90 attenuated the phosphorylation of p38 induced by NaHS
Figs. 2 and 4). Autophosphorylation of p38 have been described
o take place during noncanonical p38 activation, which occurs by
estabilization of an Hsp90-Cdc37-p38 complex [80]. Due to the
trong ability of p38 and Hsp90 inhibitors to attenuate the effect of
aHS, it is possible that H2S induces p38 phosphorylation through
uch noncanonical activation by sulfhydration of this complex, fol-
owed by p38 autophosphorylation. Further evaluation of possible
ulfhydration of cysteines in Hsp90, Cdc37 or p38 itself may  iden-
ify a more precise mechanism of NaHS-induced phosphorylation
f p38. The absent effect of the geldanamycin analog 17-AAG in our
ssay (Fig. 4a) is consistent with a previous report where 17-AAG
as a weaker p38-activator compared to geldanamycin [80]. Chela-
ion of intracellular calcium attenuated the phosphorylation of both
38 (Fig. 2e) and Akt (Fig. 5h). Interestingly, BAPTA-AM treatment
s reported to modulate the architecture of Hsp90 protein com-
lexes [81], and both p38 and Akt is known to form complexes with
sp90 [80,82]. Preincubation with BAPTA-AM could therefore pos-
ibly reorganize the protein complexes in such a way that NaHS no
onger leads to activation of signaling. This is in accordance with Akt
hosphorylation being only partly dependent on p38-Akt crosstalk
Fig. 5a-c). However, the Akt phosphorylation may  also be due to
nactivated phosphatase and tensin homolog (PTEN) by NaSH [66].search 113 (2016) 216–227 225
Most inhibitors of PKC did not alter the effect of NaHS on p38,
except for chelerythrine, which alone induced phosphorylation of
p38, possibly masking the effect of NaHS (Fig. 3d). This is sup-
ported by the fact that chelerythrine is also known to activate p38
through an unknown PKC-independent mechanism [83]. Based on
this and the lacking effect of the other PKC inhibitors used, we
consider it unlikely that activation of PKC caused p38 phosphory-
lation induced by NaHS in PBMCs. Chelating extracellular calcium
with EGTA or BAPTA (Fig. 2a-c, e), or inhibiting IP3R, calmodulin
or CaMKII (Fig. 3a–c) did not prevent signaling induced by NaHS.
This indicates that phosphorylation of p38 by NaHS is not a down-
stream effect of calcium inﬂux, calcium release from the ER or
calmodulin dependent signaling. H2S can also induce inhibition
of mitochondrial respiration [57], and this may  be sensed by the
metabolic switch AMP-activated protein kinase (AMPK) upstream
of p38 [84]. No signiﬁcant reduction in concentration of ATP in
PBMCs was detected upon stimulation with NaHS. The highest
concentration NaHS did show a clear non-signiﬁcant reduction in
ATP, but phosphorylation of p38 was induced at lower concentra-
tions. Also, sulﬁde-induced phosphorylation of p38 is reported to
be dependent on KATP channels in endothelial cells [35], however,
NaSH-induced p-p38 was not attenuated by glibenclamide in the
present study (Fig. 4a).
In conclusion, NaHS induces concentration-dependent signaling
with p38, Akt and CREB/ATF1 involved in human PBMCs. Reduced
effect of NaHS by intracellular calcium chelation and inhibitors tar-
geting p38 and Hsp90 suggest that the mechanism of activation
could be through non-canonical activation of p38. Future studies
should investigate possible targets of sulfhydration and address if
H2S or derived polysulﬁdes functionally inﬂuence differentiation
of monocytes towards an anti-inﬂammatory macrophage subset.
Authors contributions
BTG and AS designed and planned the study. AS conducted in
vitro experiments and ﬂow cytometry analyzes. AS, SG, LB, JS and
SG conducted the mass cytometry analysis. AS performed the sta-
tistical analyzes. DM carried out the automated small molecule
inhibitor phosphoﬂow screen. BTG and AS wrote the manuscript.
All authors read, edited and approved the ﬁnal manuscript. The
authors declare no conﬂict of interest.
Funding
This study was performed with funding from the The Research
Council of Norway (Petromaks program grant #220759).
Acknowledgments
We  are thankful for Bergen Research Foundation and their sup-
port to the University of Bergen for the mass cytometer equipment
used in this study. We also thank Dr. Vibeke Andresen for valuable
discussions and Samantha Scarlett for proofreading the manuscript.
Appendix A. Supplementary data
Supplementary data associated with this article can be found,
in the online version, at http://dx.doi.org/10.1016/j.phrs.2016.08.
018.
References[1] N. Dufton, J. Natividad, E.F. Verdu, J.L. Wallace, Hydrogen sulﬁde and
resolution of acute inﬂammation: a comparative study utilizing a novel
ﬂuorescent probe, Sci. Rep. 2 (2012) 499.
[2] M.  Whiteman, L. Li, P. Rose, C.H. Tan, D.B. Parkinson, P.K. Moore, The effect of
hydrogen sulﬁde donors on lipopolysaccharide-induced formation of
2 ical Re
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[26 A. Sulen et al. / Pharmacolog
inﬂammatory mediators in macrophages, Antioxid. Redox Signal. 12 (2010)
1147–1154.
[3] M.  Whiteman, P.G. Winyard, Hydrogen sulﬁde and inﬂammation: the good,
the  bad, the ugly and the promising, Expert Rev. Clin. Pharmacol. 4 (2011)
13–32.
[4] C. Coletta, K. Modis, B. Szczesny, A. Brunyanszki, G. Olah, E.C. Rios, K. Yanagi,
A.  Ahmad, A. Papapetropoulos, C. Szabo, Regulation of vascular tone,
angiogenesis and cellular bioenergetics by the 3-mercaptopyruvate
sulfurtransferase/H2S pathway: functional impairment by hyperglycemia and
restoration by DL-alpha-lipoic acid, Mol. Med. 21 (2015) 1–14.
[5] T. Chiku, D. Padovani, W.D. Zhu, S. Singh, V. Vitvitsky, R. Banerjee, H2S
biogenesis by human cystathionine gamma-lyase leads to the novel sulfur
metabolites lanthionine and homolanthionine and is responsive to the grade
of  hyperhomocysteinemia, J. Biol. Chem. 284 (2009) 11601–11612.
[6] S. Singh, D. Padovani, R.A. Leslie, T. Chiku, R. Banerjee, Relative contributions
of  cystathionine beta-synthase and gamma-cystathionase to H2S biogenesis
via  alternative trans-sulfuration reactions, J. Biol. Chem. 284 (2009)
22457–22466.
[7] N. Shibuya, Y. Mikami, Y. Kimura, N. Nagahara, H. Kimura, Vascular
endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces
hydrogen sulﬁde, J. Biochem. 146 (2009) 623–626.
[8] X. Shen, E.A. Peter, S. Bir, R. Wang, C.G. Kevil, Analytical measurement of
discrete hydrogen sulﬁde pools in biological specimens, Free Radic. Biol. Med.
52  (2012) 2276–2283.
[9] N.L. Whitﬁeld, E.L. Kreimier, F.C. Verdial, N. Skovgaard, K.R. Olson, Reappraisal
of  H2S/sulﬁde concentration in vertebrate blood and its potential signiﬁcance
in  ischemic preconditioning and vascular signaling, Am.  J. Physiol. Regul.
Integr. Comp. Physiol. 294 (2008) R1930–R1937.
10] L. Li, M.  Bhatia, Y.Z. Zhu, Y.C. Zhu, R.D. Ramnath, Z.J. Wang, F.B.M. Anuar, M.
Whiteman, M.  Salto-Tellez, P.K. Moore, Hydrogen sulﬁde is a novel mediator
of lipopolysaccharide-induced inﬂammation in the mouse, FASEB J. 19 (2005)
1196–1198.
11] Y.Y. Mok, M.S. Atan, C. Yoke Ping, W.  Zhong Jing, M.  Bhatia, S. Moochhala, P.K.
Moore, Role of hydrogen sulphide in haemorrhagic shock in the rat:
protective effect of inhibitors of hydrogen sulphide biosynthesis, Br. J.
Pharmacol. 143 (2004) 881–889.
12] E.A. Peter, X. Shen, S.H. Shah, S. Pardue, J.D. Glawe, W.W.  Zhang, P. Reddy, N.I.
Akkus, J. Varma, C.G. Kevil, Plasma free H2S levels are elevated in patients
with cardiovascular disease, J. Am.  Heart Assoc. 2 (2013) e000387.
13] M.  Whiteman, R. Haigh, J.M. Tarr, K.M. Gooding, A.C. Shore, P.G. Winyard,
Detection of hydrogen sulﬁde in plasma and knee-joint synovial ﬂuid from
rheumatoid arthritis patients: relation to clinical and laboratory measures of
inﬂammation, Ann. N.Y. Acad. Sci. 1203 (2010) 146–150.
14] N. Muniraj, L.K. Stamp, A. Badiei, A. Hegde, V. Cameron, M.  Bhatia, Hydrogen
sulﬁde acts as a pro-inﬂammatory mediator in rheumatic disease, Int. J.
Rheum. Dis. (2014).
15] K.R. Olson, The therapeutic potential of hydrogen sulﬁde: separating hype
from hope, Am.  J. Physiol. Regul. Integr. Comp. Physiol. 301 (2011) R297–312.
16] J.L. Wallace, R. Wang, Hydrogen sulﬁde-based therapeutics: exploiting a
unique but ubiquitous gasotransmitter, Nat. Rev. Drug Discov. 14 (2015)
329–345.
17] E. Ekundi-Valentim, K.T. Santos, E.A. Camargo, A. Denadai-Souza, S.A. Teixeira,
C.I.  Zanoni, A.D. Grant, J. Wallace, M.N. Muscara, S.K. Costa, Differing effects of
exogenous and endogenous hydrogen sulphide in carrageenan-induced knee
joint synovitis in the rat, Br. J. Pharmacol. 159 (2010) 1463–1474.
18] S. Fiorucci, E. Antonelli, E. Distrutti, G. Rizzo, A. Mencarelli, S. Orlandi, R.
Zanardo, B. Renga, M.  Di Sante, A. Morelli, G. Cirino, J.L. Wallace, Inhibition of
hydrogen sulﬁde generation contributes to gastric injury caused by
anti-inﬂammatory nonsteroidal drugs, Gastroenterology 129 (2005)
1210–1224.
19] I. Hirata, Y. Naito, T. Takagi, K. Mizushima, T. Suzuki, T. Omatsu, O. Handa, H.
Ichikawa, H. Ueda, T. Yoshikawa, Endogenous hydrogen sulﬁde is an
anti-inﬂammatory molecule in dextran sodium sulfate-induced colitis in
mice, Digest. Dis. Sci. 56 (2011) 1379–1386.
20] J.L. Wallace, M.  Dicay, W.  McKnight, G.R. Martin, Hydrogen sulﬁde enhances
ulcer healing in rats, FASEB J. 21 (2007) 4070–4076.
21] J.L. Wallace, L. Vong, W.  McKnight, M.  Dicay, G.R. Martin, Endogenous and
exogenous hydrogen sulﬁde promotes resolution of colitis in rats,
Gastroenterology 137 (2009) 569–578.
22] P.P. Tak, G.S. Firestein, NF-kappaB. a key role in inﬂammatory diseases, J. Clin.
Invest. 107 (2001) 7–11.
23] U.J. Lee, S.R. Choung, K.V.B. Prakash, E.J. Lee, M.Y. Lee, Y.J. Kim, C.W. Han, Y.C.
Chol, Dual knockdown of p65 and p50 subunits of NF-kappaB by siRNA
inhibits the induction of inﬂammatory cytokines and signiﬁcantly enhance
apoptosis in human primary synoviocytes treated with tumor necrosis
factor-alpha, Mol. Biol. Rep. 35 (2008) 291–298.
24] A. Banerjee, S. Gerondakis, Coordinating TLR-activated signaling pathways in
cells of the immune system, Immunol. Cell Biol. 85 (2007) 420–424.
25] D. Brenner, H. Blaser, T.W. Mak, Regulation of tumour necrosis factor
signalling: live or let die, Nat. Rev. Immunol. 15 (2015) 362–374.
26] Z. Guan, S.Y. Buckman, A.P. Pentland, D.J. Templeton, A.R. Morrison, Induction
of cyclooxygenase-2 by the activated MEKK1 −> SEK1/MKK4 −> p38
mitogen-activated protein kinase pathway, J. Biol. Chem. 273 (1998)
12901–12908.
27] D.G. Perregaux, D. Dean, M.  Cronan, P. Connelly, C.A. Gabel, Inhibition of
interleukin-1 beta production by SKF86002: evidence of two  sites of in vitro
[search 113 (2016) 216–227
activity and of a time and system dependence, Mol. Pharmacol. 48 (1995)
433–442.
28] T. Tomida, M.  Takekawa, H. Saito, Oscillation of p38 activity controls efﬁcient
pro-inﬂammatory gene expression, Nat. Commun. 6 (2015) 8350.
29] C. Chen, Y.H. Chen, W.W.  Lin, Involvement of p38 mitogen-activated protein
kinase in lipopolysaccharide-induced iNOS and COX-2 expression in J774
macrophages, Immunology 97 (1999) 124–129.
30] K. Gee, J.B. Angel, S. Mishra, M.A. Blahoianu, A. Kumar, IL-10 regulation by
HIV-Tat in primary human monocytic cells: involvement of
calmodulin/calmodulin-dependent protein kinase-activated p38 MAPK and
Sp-1 and CREB-1 transcription factors, J. Immunol. 178 (2007) 798–807.
31] N. Sen, B.D. Paul, M.M. Gadalla, A.K. Mustafa, T. Sen, R.S. Xu, S. Kim, S.H.
Snyder, Hydrogen sulﬁde-linked sulfhydration of NF-kappa B mediates its
antiapoptotic actions, Mol. Cell. 45 (2012) 13–24.
32] J. Du, Y. Huang, H. Yan, Q. Zhang, M.  Zhao, M.  Zhu, J. Liu, S.X. Chen, D. Bu, C.
Tang, H. Jin, Hydrogen sulﬁde suppresses oxidized low-density lipoprotein
(ox-LDL)-stimulated monocyte chemoattractant protein 1 generation from
macrophages via the nuclear factor kappaB (NF-kappaB) pathway, J. Biol.
Chem. 289 (2014) 9741–9753.
33] G. Yang, W.  Yang, L. Wu,  R. Wang, H2S, endoplasmic reticulum stress, and
apoptosis of insulin-secreting beta cells, J. Biol. Chem. 282 (2007)
16567–16576.
34] G. Yang, X. Sun, R. Wang, Hydrogen sulﬁde-induced apoptosis of human aorta
smooth muscle cells via the activation of mitogen-activated protein kinases
and caspase-3, FASEB J. 18 (2004) 1782–1784.
35] A. Papapetropoulos, A. Pyriochou, Z. Altaany, G.D. Yang, A. Marazioti, Z.M.
Zhou, M.G. Jeschke, L.K. Branski, D.N. Herndon, R. Wang, C. Szabo, Hydrogen
sulﬁde is an endogenous stimulator of angiogenesis, Proc. Natl. Acad. Sci. U. S.
A. 106 (2009) 21972–21977.
36] L. Zhao, Y. Wang, Q. Yan, W.  Lv, Y. Zhang, S. He, Exogenous hydrogen sulﬁde
exhibits anti-cancer effects though p38 MAPK signaling pathway in C6 glioma
cells,  Biol. Chem. 396 (2015) 1247–1253.
37] L. Rinaldi, G. Gobbi, M.  Pambianco, C. Micheloni, P. Mirandola, M.  Vitale,
Hydrogen sulﬁde prevents apoptosis of human PMN  via inhibition of p38 and
caspase 3, Lab. Invest. 86 (2006) 391–397.
38] H. Enslen, H. Tokumitsu, P.J. Stork, R.J. Davis, T.R. Soderling, Regulation of
mitogen-activated protein kinases by a calcium/calmodulin-dependent
protein kinase cascade, Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 10803–10808.
39] K. Takeda, A. Matsuzawa, H. Nishitoh, K. Tobiume, S. Kishida, J.
Ninomiya-Tsuji, K. Matsumoto, H. Ichijo, Involvement of ASK1 in
Ca2+-induced p38 MAP  kinase activation, EMBO Rep. 5 (2004) 161–166.
40] K. Nakajima, Y. Tohyama, S. Kohsaka, T. Kurihara, Protein kinase C alpha
requirement in the activation of p38 mitogen-activated protein kinase, which
is linked to the induction of tumor necrosis factor alpha in
lipopolysaccharide-stimulated microglia, Neurochem. Int. 44 (2004) 205–214.
41] T.T. Pan, K.L. Neo, L.F. Hu, Q.C. Yong, J.S. Bian, H2S preconditioning-induced
PKC activation regulates intracellular calcium handling in rat cardiomyocytes,
Am.  J. Physiol. Cell Physiol. 294 (2008) C169–177.
42] S.F. Steinberg, Structural basis of protein kinase C isoform function, Physiol.
Rev. 88 (2008) 1341–1378.
43] Y. Nagai, M. Tsugane, J. Oka, H. Kimura, Hydrogen sulﬁde induces calcium
waves in astrocytes, FASEB J. 18 (2004) 557–559.
44] V.A. McGuire, A. Gray, C.E. Monk, S.G. Santos, K. Lee, A. Aubareda, J. Crowe, N.
Ronkina, J. Schwermann, I.H. Batty, N.R. Leslie, J.L. Dean, S.J. O’Keefe, M.
Boothby, M.  Gaestel, J.S. Arthur, Cross talk between the Akt and p38alpha
pathways in macrophages downstream of Toll-like receptor signaling, Mol.
Cell  Biol. 33 (2013) 4152–4165.
45] M.J. Rane, P.Y. Coxon, D.W. Powell, R. Webster, J.B. Klein, W.  Pierce, P. Ping,
K.R. McLeish, p38 Kinase-dependent MAPKAPK-2 activation functions as
3-phosphoinositide-dependent kinase-2 for Akt in human neutrophils, J. Biol.
Chem. 276 (2001) 3517–3523.
46] Y. Zhou, D. Wang, X. Gao, K. Lew, A.M. Richards, P. Wang, mTORC2
phosphorylation of Akt1: a possible mechanism for hydrogen sulﬁde-induced
cardioprotection, PLoS One 9 (2014) e99665.
47] R. Tamizhselvi, J. Sun, Y.H. Koh, M.  Bhatia, Effect of hydrogen sulﬁde on the
phosphatidylinositol 3-kinase-protein kinase B pathway and on
caerulein-induced cytokine production in isolated mouse pancreatic acinar
cells, J. Pharmacol. Exp. Ther. 329 (2009) 1166–1177.
48] Z. Altaany, G.D. Yang, R. Wang, Crosstalk between hydrogen sulﬁde and nitric
oxide in endothelial cells, J. Cell Mol. Med. 17 (2013) 879–888.
49] C. Rocher, D.K. Singla, SMAD-PI3K-Akt-mTOR pathway mediates BMP-7
polarization of monocytes into M2  macrophages, PLoS One 8 (2013).
50] A. Sulen, S.H. Lygre, S.M. Hjelle, B.E. Hollund, B.T. Gjertsen, Elevated monocyte
phosphorylated p38 in nearby employees after a chemical explosion, Sci. Rep.
6  (2016) 29060.
51] B. Bodenmiller, E.R. Zunder, R. Finck, T.J. Chen, E.S. Savig, R.V. Bruggner, E.F.
Simonds, S.C. Bendall, K. Sachs, P.O. Krutzik, G.P. Nolan, Multiplexed mass
cytometry proﬁling of cellular states perturbed by small-molecule regulators,
Nat.  Biotechnol. 30 (2012) 858–867.
52] J.M. Irish, D.K. Czerwinski, G.P. Nolan, R. Levy, Altered B-cell receptor
signaling kinetics distinguish human follicular lymphoma B cells from
tumor-inﬁltrating nonmalignant B cells, Blood 108 (2006) 3135–3142.
53] S. Gavasso, S.E. Gullaksen, J. Skavland, B.T. Gjertsen, Single-cell proteomics:
potential implications for cancer diagnostics, Expert Rev. Mol. Daign. (2016)
1–11.
ical Re
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
9612–9619.A. Sulen et al. / Pharmacolog
54] P.O. Krutzik, G.P. Nolan, Fluorescent cell barcoding in ﬂow cytometry allows
high-throughput drug screening and signaling proﬁling, Nat. Methods 3
(2006) 361–368.
55] J. Skavland, K.M. Jorgensen, K. Hadziavdic, R. Hovland, I. Jonassen, O.
Bruserud, B.T. Gjertsen, Speciﬁc cellular signal-transduction responses to
in  vivo combination therapy with ATRA, valproic acid and theophylline in
acute myeloid leukemia, Blood Cancer J. 1 (2011) e4.
56] A.D. Amir el, K.L. Davis, M.D. Tadmor, E.F. Simonds, J.H. Levine, S.C. Bendall,
D.K. Shenfeld, S. Krishnaswamy, G.P. Nolan, D. Pe’er, viSNE enables
visualization of high dimensional single-cell data and reveals phenotypic
heterogeneity of leukemia, Nat. Biotechnol. 31 (2013) 545–552.
57] C. Szabo, C. Ransy, K. Modis, M.  Andriamihaja, B. Murghes, C. Coletta, G. Olah,
K.  Yanagi, F. Bouillaud, Regulation of mitochondrial bioenergetic function by
hydrogen sulﬁde: part I. Biochemical and physiological mechanisms, Br. J.
Pharmacol. 171 (2014) 2099–2122.
58] K. Mikoshiba, M.  Hattori, IP3 receptor-operated calcium entry, Sci. Signal.
2000 (2000) pe1.
59] E. Hosoi, C. Nishizaki, K.L. Gallagher, H.W. Wyre, Y. Matsuo, Y. Sei, Expression
of  the ryanodine receptor isoforms in immune cells, J. Immunol. 167 (2001)
4887–4894.
60] J.T. Lanner, D.K. Georgiou, A.D. Joshi, S.L. Hamilton, Ryanodine receptors:
structure, expression, molecular details, and function in calcium release, Cold
Spring Harb. Perspect. Biol. 2 (2010) a003996.
61] J. Furne, A. Saeed, M.D. Levitt, Whole tissue hydrogen sulﬁde concentrations
are orders of magnitude lower than presently accepted values, Am.  J. Physiol.
Regul. Integr. Comp. Physiol. 295 (2008) R1479–1485.
62] K.R. Olson, Is hydrogen sulﬁde a circulating gasotransmitter in vertebrate
blood? BBA-Bioenergetics 1787 (2009) 856–863.
63] G.K. Kolluru, X. Shen, S.C. Bir, C.G. Kevil, Hydrogen sulﬁde chemical biology:
pathophysiological roles and detection, Nitric Oxide 35 (2013) 5–20.
64] O. Kabil, R. Banerjee, Redox biochemistry of hydrogen sulﬁde, J. Biol. Chem.
285 (2010) 21903–21907.
65] S.U. Nigwekar, D. Kroshinsky, R.M. Nazarian, J. Goverman, R. Malhotra, V.A.
Jackson, M.M.  Kamdar, D.J. Steele, R.I. Thadhani, Calciphylaxis: risk factors,
diagnosis, and treatment, Am.  J. Kidney Dis. 66 (2015) 133–146.
66] R. Greiner, Z. Palinkas, K. Basell, D. Becher, H. Antelmann, P. Nagy, T.P. Dick,
Polysulﬁdes link H2S to protein thiol oxidation, Antioxid. Redox Signal. 19
(2013) 1749–1765.
67] Y. Kimura, Y. Mikami, K. Osumi, M.  Tsugane, J. Oka, H. Kimura, Polysulﬁdes are
possible H2S-derived signaling molecules in rat brain, FASEB J. 27 (2013)
2451–2457.
68] L. Zeng, S. Chen, T. Xia, W.  Hu, C. Li, Z. Liu, Two-photon ﬂuorescent probe for
detection of exogenous and endogenous hydrogen persulﬁde and polysulﬁde
in living organisms, Anal. Chem. 87 (2015) 3004–3010.69] H. Kimura, Signaling molecules: hydrogen sulﬁde and polysulﬁde, Antioxid.
Redox Signal. 22 (2015) 362–376.
70] N. Krishnan, C. Fu, D.J. Pappin, N.K. Tonks, H2S-Induced sulfhydration of the
phosphatase PTP1B and its role in the endoplasmic reticulum stress response,
Sci. Signal. 4 (2011) ra86.
[search 113 (2016) 216–227 227
71] J.L. Dean, M.  Brook, A.R. Clark, J. Saklatvala, p38 mitogen-activated protein
kinase regulates cyclooxygenase-2 mRNA stability and transcription in
lipopolysaccharide-treated human monocytes, J. Biol. Chem. 274 (1999)
264–269.
72] S.F. Ang, S.W. Sio, S.M. Moochhala, P.A. MacAry, M. Bhatia, Hydrogen sulﬁde
upregulates cyclooxygenase-2 and prostaglandin E metabolite in
sepsis-evoked acute lung injury via transient receptor potential vanilloid type
1  channel activation, J. Immunol. 187 (2011) 4778–4787.
73] D. Hammaker, G.S. Firestein, Go upstream, young man: lessons learned from
the p38 saga, Ann. Rheum. Dis. 69 (Suppl. 1) (2010) i77–82.
74] A. Arranz, C. Doxaki, E. Vergadi, Y. Martinez de la Torre, K. Vaporidi, E.D.
Lagoudaki, E. Ieronymaki, A. Androulidaki, M.  Venihaki, A.N. Margioris, E.N.
Stathopoulos, P.N. Tsichlis, C. Tsatsanis, Akt1 and Akt2 protein kinases
differentially contribute to macrophage polarization, Proc. Natl. Acad. Sci. U.
S.  A. 109 (2012) 9517–9522.
75] P. Italiani, D. Boraschi, From monocytes to M1/M2  macrophages:
phenotypical vs: functional differentiation, Front. Immunol. 5 (2014) 514.
76] L. Miao, X. Shen, M.  Whiteman, H. Xin, Y. Shen, X. Xin, P.K. Moore, Y.Z. Zhu,
Hydrogen sulﬁde mitigates myocardial infarction via promotion of
mitochondrial biogenesis-dependent m2 polarization of macrophages,
Antioxid. Redox Signal. 25 (2016) 268–281.
77] M.  Bucci, A. Papapetropoulos, V. Vellecco, Z.M. Zhou, A. Pyriochou, C. Roussos,
F.  Roviezzo, V. Brancaleone, G. Cirino, Hydrogen sulﬁde is an endogenous
inhibitor of phosphodiesterase activity, Arterioscl. Throm. Vas. 30 (2010)
1998–2004.
78] R. Wang, Physiological implications of hydrogen sulﬁde: a whiff exploration
that blossomed, Physiol. Rev. 92 (2012) 791–896.
79] P. Heneberg, Reactive nitrogen species and hydrogen sulﬁde as regulators of
protein tyrosine phosphatase activity, Antioxid. Redox Sign. 20 (2014)
2191–2209.
80] A. Ota, J. Zhang, P.P. Ping, J.H. Han, Y.B. Wang, Speciﬁc regulation of
noncanonical p38 alpha activation by Hsp90-Cdc37 chaperone complex in
cardiomyocyte, Circ. Res. 106 (2010) 1404–1412.
81] S. Takahashi, M.E. Mendelsohn, Synergistic activation of endothelial
nitric-oxide synthase (eNOS) by HSP90 and Akt: calcium-independent eNOS
activation involves formation of an HSP90-Akt-CaM-bound eNOS complex, J.
Biol. Chem. 278 (2003) 30821–30827.
82] O. Franzese, S.M. Henson, C. Naro, E. Bonmassar, Defect in HSP90 expression
in  highly differentiated human CD8(+) T lymphocytes, Cell. Death. Dis. 5
(2014) e1294.
83] R. Yu, S. Mandlekar, T.H. Tan, A.N. Kong, Activation of p38 and c-Jun
N-terminal kinase pathways and induction of apoptosis by chelerythrine do
not require inhibition of protein kinase C, J. Biol. Chem. 275 (2000)84] J. Li, E.J. Miller, J. Ninomiya-Tsuji, R.R. Russell, 3rd, Young LH. AMP-activated
protein kinase activates p38 mitogen-activated protein kinase by increasing
recruitment of p38 MAPK to TAB1 in the ischemic heart, Circ. Res. 97 (2005)
872–879.
